Pneumonitis and multiple pneumonial infections under combined immune‐checkpoint inhibition
Abstract The introduction of immune checkpoint inhibitors and targeted therapies has revolutionized melanoma treatment. The downside are immune‐mediated adverse events which are frequent and require close patient management. We report a case of severe immune‐mediated hepatitis and pneumonitis under...
Saved in:
Main Authors: | Kristine E. Mayer (Author), Thomas Gan (Author), Jochen Gaa (Author), Tilo Biedermann (Author), Christian Posch (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis
by: Ke Ma, et al.
Published: (2018) -
Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma
by: Anica Högner, et al.
Published: (2021) -
Novel Combination Strategies to Enhance Immune Checkpoint Inhibition in Cancer Immunotherapy: A Narrative Review
by: Jonathan A. Hermel, et al.
Published: (2020) -
MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer
by: Julius Strauss
Published: (2017) -
Successful treatment of pyoderma gangrenosum with Janus kinase 1/2 inhibition
by: Sebastian Sitaru, et al.
Published: (2022)